Despite criticism of the FDA review process, new cancer drugs reach patients sooner in the United States than in Europe. | April 7, 2016 Share
Considerations for the successful co-development of targeted cancer therapies and companion diagnostics. | April 7, 2016 Share
Use of multiple endpoints and approval paths depicts a decade of FDA oncology drug approvals. | April 7, 2016 Share
Regulatory watch: Impact of breakthrough therapy designation on cancer drug development | April 7, 2016 Share
A Century of Medical Product Regulation: The Historic Framework for Medical Product Regulation | April 7, 2016 Share
